Dupilumab with Topical Corticosteroids Provides Rapid and Sustained Improvement in Adults with Moderate-to-Severe Atopic Dermatitis Across Anatomic Regions Over 52 Weeks.
Andrew BlauveltMarjolein de Bruin-WellerEric L SimpsonZhen ChenAnnie ZhangBrad ShumelPublished in: Dermatology and therapy (2021)
LIBERTY AD CHRONOS (NCT02260986).